Catabasis Pharmaceuticals, Inc. appointed Jonathan Violin and Fred Callori to the Board as directors. Dr. Violin will serve as a Class III director with a term expiring at the company’s 2021 annual meeting of the stockholders of the company and until such time as his successor is duly elected and qualified, or until his earlier death, resignation or removal. Mr. Callori will serve as a Class I director with a term expiring at the company’s 2022 annual meeting of the stockholders of the company and until such time as his successor is duly elected and qualified, or until his earlier death, resignation or removal.